European Parliament rejects criteria endocrine-disrupting chemicals

The European Parliament has rejected the European Commission’s proposed criteria for identifying endocrine-disrupting chemicals. These criteria, in their current form, would not sufficiently protect our health. The European Commission will therefore have to go back to the drawing board. Wemos applauds the Parliament’s decision, as this is another step closer towards protecting our health and environment.

In our letter to European Members of Parliament (MEPs) last week, we urged them to reject the proposed criteria, which we found to be flawed and unfit for purpose. Flaws included the unrealistically high proposed burden of proof for identifying the substances, and the exemption of certain pesticides and biocides intended to disrupt the hormone system. The criteria would therefore harm public health. In our joint letter to MEPs – together with the organizations Health and Environment Alliance (HEAL) and Women Engage for a Common Future (WECF International) – we pressed for robust criteria.


New opportunity

With the rejection of the criteria, the European Commission now gets another opportunity to put health first in a new proposal. Wemos will continue pressing for robust criteria for identifying endocrine-disrupting chemicals. Wemos’ global health advocate Annelies den Boer: ‘This has shown that the European Parliament takes science and the health of European citizens seriously. Wemos applauds this, because in order to protect the health of Dutch citizens, we will need better criteria.’


Read our letter to MEPs (Dutch)

Read our other article on this topic and the EP

What are endocrine-disrupting chemicals? Why do we want robust criteria? Read our factsheet (Dutch) and more on the themepage

Read HEAL’s press release

Recent News items

The Foreign Trade and Development Cooperation policy document does not sufficiently address access to healthcare for poorer people


The new policy paper of Minister Schreinemacher of Foreign Trade and Development Cooperation, “Doen waar Nederland goed in is (“Doing what the Netherlands is good at”), is very much focused on Dutch business interests and seems to have insufficient attention for realising access to health care for poorer population groups. The Minister indicates that she wants to invest more in public-private collaborations in low- and middle-income countries, also in healthcare. As a result, there is a great risk that healthcare will become more commercial and therefore unaffordable for people with fewer financial resources. To provide good healthcare, the Minister should, instead, contribute to strengthening the capacity and financial resources in the public sector. 

Continue reading

What are best practices to address brain drain of health workers?


What are best (regional) practices when it comes to addressing brain drain – i.e. the emigration of skilled workers, including health workers – and what action is needed on EU level? With this open consultation, the European Commission is interested in feedback on the scale and dynamics of brain drain, and in successful practices and regional strategies and policies to tackle the emigration of qualified workers. Wemos has provided input to the consultation. We recommend, for example, that EU Member States use existing instruments to implement policies and strategies based on evidence, to strengthen their health workforce.

Continue reading